Rash Morphology as a Predictor of COVID-19 Severity: A Systematic Review of the Cutaneous Manifestations of COVID-19

    May 2022 in “ Skin health and disease ”
    Zachary Holmes, Ashling Courtney, Marc Lincoln, Richard Weller
    Image of study
    TLDR Certain types of rashes in COVID-19 patients may indicate more severe illness and higher risk of death.
    This systematic review analyzed 240 papers and 2056 patients to study the relationship between rash morphology and COVID-19 severity. The most common skin manifestation was chilblain-like lesions (54.2%), followed by maculopapular (13.6%) and urticaria (8.3%). The study found a significant relationship between rash type and COVID-19 severity, with 20.9% of patients having a rash as their only symptom. Acro-ischaemia and livedo reticularis were associated with a higher risk of ICU transfer and mortality. The most common dermatological symptoms were pruritus (35.1%), pain (16.4%), and burning (4.7%). Hair and nail changes were observed in 1.9% of cases, typically 3 months after the COVID-19 episode. The study suggests that rash morphology could be a useful prognostic tool in managing COVID-19.
    Discuss this study in the Community →

    Related Community Posts Join

    6 / 11 results

      community 5 Months Dutasteride 0.5mg 1x Daily Results

      in Progress Pictures  28 upvotes 6 months ago
      A user shared their positive results after 5 months of taking Dutasteride 0.5 mg daily, with no side effects, and recently started taking 2.5 mg oral Minoxidil. They reported thicker hair and no issues like brain fog.

      community never give up (19 to 21 years old)

      in Progress Pictures  281 upvotes 2 months ago
      The conversation is about a person recovering from drug-induced malnourishment, regaining hair growth, and improving overall health. They attribute their progress to stopping drug use, focusing on nutrition, and possibly using hormone replacement therapy (HRT).

    Similar Research

    5 / 202 results